Ligand validation:1NR5

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 1NR5 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1NR5_NAD_A_400	97%	12%	0.071	0.983	2.38	1.74	11	8	1	0	100%	1
1NR5_NAD_B_401	92%	11%	0.082	0.974	2.47	1.72	11	9	1	0	100%	1
1SG6_NAD_B_1401	95%	12%	0.074	0.978	2.36	1.73	11	9	0	0	100%	1
1NVE_NAD_C_402	88%	11%	0.099	0.975	2.43	1.74	11	9	1	0	100%	1
1NRX_NAD_B_401	82%	17%	0.123	0.978	1.88	1.74	11	10	0	0	100%	1
1NVB_NAD_A_400	20%	16%	0.256	0.861	1.93	1.77	12	10	3	0	100%	1
2O2Y_NAD_B_1450	100%	23%	0.024	0.995	1.79	1.4	5	3	1	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.